Swipe om te navigeren naar een ander artikel
The online version of this article (doi:10.1007/s11136-016-1398-z) contains supplementary material, which is available to authorized users.
Value-based healthcare is an upcoming field. The core idea is to evaluate care based on achieved outcomes divided by the costs. Unfortunately, the optimal way to evaluate outcomes is ill-defined. In this study, we aim to develop a single, preference based, outcome metric, which can be used to quantify overall health value in inflammatory bowel disease (IBD).
IBD patients filled out a choice-based conjoint (CBC) questionnaire in which patients chose preferable outcome scenarios with different levels of disease control (DC), quality of life (QoL), and productivity (Pr). A CBC analysis was performed to estimate the relative value of DC, QoL, and Pr. A patient-centered composite score was developed which was weighted based on the stated preferences.
We included 210 IBD patients. Large differences in stated preferences were observed. Increases from low to intermediate outcome levels were valued more than increases from intermediate to high outcome levels. Overall, QoL was more important to patients than DC or Pr. Individual outcome scores were calculated based on the stated preferences. This score was significantly different from a score not weighted based on patient preferences in patients with active disease.
We showed the feasibility of creating a single outcome metric in IBD which incorporates patients’ values using a CBC. Because this metric changes significantly when weighted according to patients’ values, we propose that success in healthcare should be measured accordingly.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Supplementary material 1 (DOCX 23 kb)11136_2016_1398_MOESM1_ESM.docx
Porter, M. E., & Teisberg, E. O. (2004). Redefining competition in health care. Harvard Business Review, 82(6), 64–76. PubMed
Blumenthal, D., & Stremikis, K. (2013). Getting real about health care value. Harvard Business Review, Digital Article. https://hbr.org/2013/09/getting-real-about-health-care-value. Accessed 24 Aug 2016
American Gastroenterological Association. Performance Measures (2015). http://www.gastro.org/practice-management/quality/performance-measures. Accessed 14 October 2015.
Melmed, G. Y., & Siegel, C. A. (2013). Quality improvement in inflammatory bowel disease. Gastroenterol Hepatol (N Y), 9(5), 286–292.
Stacey, D., Legare, F., Col, N. F., Bennett, C. L., Barry, M. J., Eden, K. B., et al. (2014). Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, 1, Cd001431. doi: 10.1002/14651858.CD001431.pub4.
US Department of Health and Human Services, Food and Drug Administration. Guidance for industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (December 2009).
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. Journal of Clinical Epidemiology, 63(11), 1179–1194. doi: 10.1016/j.jclinepi.2010.04.011. CrossRefPubMedPubMedCentral
Bridges, J. F., Hauber, A. B., Marshall, D., Lloyd, A., Prosser, L. A., Regier, D. A., et al. (2011). Conjoint analysis applications in health–a checklist: A report of the ISPOR good research practices for conjoint analysis task force. Value Health, 14(4), 403–413. doi: 10.1016/j.jval.2010.11.013. CrossRefPubMed
van Deen, W. K., van der Meulen-de Jong, A. E., Parekh, N. K., Muyshondt, Y., Kane, E., Eimers, L., et al. (2015). Su1230 remote monitoring of IBD disease activity using the Mobile Health Index (mHI): A validation study. Gastroenterology, 148(4), S-446. doi: 10.1016/S0016-5085(15)31501-8. CrossRef
Sawtooth Software, CBC/HB v5, Software for hierarchical Bayes estimation for CBC data. Manual. [Updated June 11, 2013]. https://www.sawtoothsoftware.com/download/techpap/CBCHB_Manual.pdf. Accessed 12 February 2016.
Orme, B. (2000). Hierarchical Bayes: Why all the attention? Quirk’s Marketing Research Review, 16, 58–63.
Wittink, D. R. (2000). Predictive validity of conjoint analysis. In Proceedings of the Sawtooth Software Conference, Sequim, WA, March 2000 (Vol. 2000, pp. 221–237).
Orme, B. (2010). Sample size issues for conjoint analysis. In B. Orme (Ed.), Getting started with conjoint analysis: Strategies for product design and pricing research. (2nd ed., pp. 57–66). Madison, WI: Research Publishers LLC.
Devlin, N., Shah, K.K., Feng, Y., Mulhern, B. & van Hout, B. (2016) Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England. OHE Research Paper. London: Office of Health Economics.
- Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients’ preferences
Welmoed K. van Deen
Natalie E. Duran
Martijn G. H. van Oijen
Daniel W. Hommes
- Springer International Publishing